(VIANEWS) – VISTIN PHARMA (VISTN.OL), TINC (TINC.BR), FORFARMERS (FFARM.AS) have the highest dividend yield stocks on this list.
| Financial Asset | Forward Dividend Yield | Updated (EST) |
|---|---|---|
| VISTIN PHARMA (VISTN.OL) | 7.71% | 2024-07-07 07:31:39 |
| TINC (TINC.BR) | 7.38% | 2024-07-07 07:15:42 |
| FORFARMERS (FFARM.AS) | 5.23% | 2024-07-07 09:01:56 |
| BAM GROEP KON (BAMNB.AS) | 4.69% | 2024-07-07 09:00:44 |
| CORTICEIRA AMORIM (COR.LS) | 4.44% | 2024-07-07 07:16:14 |
| NOKIA (NOKIA.PA) | 4.43% | 2024-07-07 10:00:44 |
| SANOFI (SAN.PA) | 4.13% | 2024-07-07 10:02:07 |
Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. VISTIN PHARMA (VISTN.OL)
7.71% Foward Dividend Yield
VISTIN PHARMA’s last close was kr21.80, 12.8% under its 52-week high of kr25.00. Intraday change was 0%.
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. Vistin Pharma ASA was founded in 1969 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, VISTIN PHARMA has a trailing twelve months EPS of kr1.27.
PE Ratio
VISTIN PHARMA has a trailing twelve months price to earnings ratio of 17.17. Meaning, the purchaser of the share is investing kr17.17 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.84%.
Volatility
VISTIN PHARMA’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.69%, a negative 0.15%, and a positive 1.58%.
VISTIN PHARMA’s highest amplitude of average volatility was 1.83% (last week), 1.42% (last month), and 1.58% (last quarter).
Sales Growth
VISTIN PHARMA’s sales growth is 10.6% for the ongoing quarter and 6.6% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 2.9%, now sitting on 441.27M for the twelve trailing months.
More news about VISTIN PHARMA.
2. TINC (TINC.BR)
7.38% Foward Dividend Yield
TINC’s last close was €11.40, 10.59% under its 52-week high of €12.75. Intraday change was 0.18%.
TINC Comm. VA is an investment firm specializing in investments in public and private infrastructure, real assets, and energy sector. TINC Comm. VA is based in Antwerpen, Belgium.
Earnings Per Share
As for profitability, TINC has a trailing twelve months EPS of €1.01.
PE Ratio
TINC has a trailing twelve months price to earnings ratio of 11.29. Meaning, the purchaser of the share is investing €11.29 for every euro of annual earnings.
More news about TINC.
3. FORFARMERS (FFARM.AS)
5.23% Foward Dividend Yield
FORFARMERS’s last close was €2.87, 1.71% under its 52-week high of €2.92. Intraday change was -0.53%.
ForFarmers N.V. provides feed solutions for conventional and organic livestock farming in the Netherlands, Belgium, Germany, Poland, the United Kingdom, other European countries, and internationally. It offers compound feed and blends, feed for young animals and specialties, raw materials and coproducts, seeds, and fertilizers. The company is involved in production and delivery of feed, as well as engaged in logistics services. ForFarmers N.V. was founded in 1896 and is based in Lochem, the Netherlands.
Earnings Per Share
As for profitability, FORFARMERS has a trailing twelve months EPS of €-0.01.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.57%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 20.3%, now sitting on 2.97B for the twelve trailing months.
Moving Average
FORFARMERS’s worth is higher than its 50-day moving average of €2.70 and way higher than its 200-day moving average of €2.48.
More news about FORFARMERS.
4. BAM GROEP KON (BAMNB.AS)
4.69% Foward Dividend Yield
BAM GROEP KON’s last close was €4.27, 0.28% under its 52-week high of €4.28. Intraday change was 1.19%.
Koninklijke BAM Groep nv, together with its subsidiaries, provides products and services in the construction and property, civil engineering, and public private partnerships (PPP) sectors worldwide. The company engages in residential construction projects, and non-residential construction activities. It is also involved in rail infrastructure and facilities management activities. Koninklijke BAM Groep nv was founded in 1869 and is headquartered in Bunnik, the Netherlands.
Earnings Per Share
As for profitability, BAM GROEP KON has a trailing twelve months EPS of €0.64.
PE Ratio
BAM GROEP KON has a trailing twelve months price to earnings ratio of 6.65. Meaning, the purchaser of the share is investing €6.65 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.23%.
Moving Average
BAM GROEP KON’s value is way higher than its 50-day moving average of €3.84 and way higher than its 200-day moving average of €3.01.
Revenue Growth
Year-on-year quarterly revenue growth grew by 0.4%, now sitting on 6.27B for the twelve trailing months.
Volume
Today’s last reported volume for BAM GROEP KON is 620711 which is 45.92% below its average volume of 1147800.
More news about BAM GROEP KON.
5. CORTICEIRA AMORIM (COR.LS)
4.44% Foward Dividend Yield
CORTICEIRA AMORIM’s last close was €9.29, 11.69% under its 52-week high of €10.52. Intraday change was -0.11%.
Corticeira Amorim, S.G.P.S., S.A. manufactures and sells cork and cork related products in Europe, the United States, Portugal, Australasia, and Africa. The company operates through Amorim Florestal, Amorim Cork, Amorim Cork Flooring, Amorim Cork Composites, Amorim Cork Insulation, and Corticeira Amorim and Others segments. It offers raw materials for cork and agroforestry markets; and cork stoppers for still and sparkling wine, spirit, beer, and cider industries. The company also provides cork composite solutions for use in various applications, such as aerospace, mobility, energy, sealing, construction, sports and recreational surfaces, maritime, flooring, home, office and leisure goods, footwear, toys, and footwear. In addition, it offers insulation cork materials for use in sustainable construction/insulation, and interior and exterior designing; and flooring solutions to floor and wall coverings markets. The company was founded in 1870 and is headquartered in Mozelos, Portugal. Corticeira Amorim, S.G.P.S., S.A. operates as a subsidiary of Amorim Investimentos e Participações, S.G.P.S., S.A.
Earnings Per Share
As for profitability, CORTICEIRA AMORIM has a trailing twelve months EPS of €0.61.
PE Ratio
CORTICEIRA AMORIM has a trailing twelve months price to earnings ratio of 15.34. Meaning, the purchaser of the share is investing €15.34 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.55%.
More news about CORTICEIRA AMORIM.
6. NOKIA (NOKIA.PA)
4.43% Foward Dividend Yield
NOKIA’s last close was €3.61, 8.14% below its 52-week high of €3.93. Intraday change was -0.71%.
Nokia Oyj provides mobile, fixed, and cloud network solutions worldwide. The company operates through four segments: Network Infrastructure, Mobile Networks, Cloud and Network Services, and Nokia Technologies. The company provides fixed networking solutions, such as fiber and copper-based access infrastructure, in-home Wi-Fi solutions, and cloud and virtualization services; IP networking solutions, including IP access, aggregation, and edge and core routing for residential, mobile, enterprise and cloud applications; optical networks solutions that provides optical transport networks for metro, regional, and long-haul applications, and subsea applications; and submarine networks for undersea cable transmission. It serves its products and services to communications service providers, webscales and hyperscalers, digital industries, and government. The company also offers mobile technology products and services for radio access networks and microwave radio links for transport networks, network management solutions, as well as network planning, optimization, network deployment, and technical support services. In addition, it offers cloud and network services, including core network solutions, such as voice and packet core; business applications, such as security, automation, and monetization; cloud and cognitive services; and enterprise solutions, including private wireless and industrial automation. Further, the company licenses intellectual property, including patents, technologies, and the Nokia brand. Nokia Oyj was founded in 1865 and is headquartered in Espoo, Finland.
Earnings Per Share
As for profitability, NOKIA has a trailing twelve months EPS of €0.12.
PE Ratio
NOKIA has a trailing twelve months price to earnings ratio of 27.46. Meaning, the purchaser of the share is investing €27.46 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.86%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 20.3%, now sitting on 21.07B for the twelve trailing months.
Moving Average
NOKIA’s worth is below its 50-day moving average of €3.53 and below its 200-day moving average of €3.31.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Apr 22, 2024, the estimated forward annual dividend rate is 0.16 and the estimated forward annual dividend yield is 4.43%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, NOKIA’s stock is considered to be overbought (>=80).
More news about NOKIA.
7. SANOFI (SAN.PA)
4.13% Foward Dividend Yield
SANOFI’s last close was €90.94, 12.83% under its 52-week high of €104.32. Intraday change was -0.87%.
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers products for itching, hydration, aging, cracking, overnight, and specialty skincare needs like eczema. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Adagene Inc., for the discovery and development of antibody-based therapies. It also has collaborations with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, SANOFI has a trailing twelve months EPS of €4.3.
PE Ratio
SANOFI has a trailing twelve months price to earnings ratio of 21.15. Meaning, the purchaser of the share is investing €21.15 for every euro of annual earnings.
Yearly Top and Bottom Value
SANOFI’s stock is valued at €90.96 at 17:50 EST, way under its 52-week high of €104.32 and way higher than its 52-week low of €80.60.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on May 13, 2024, the estimated forward annual dividend rate is 3.76 and the estimated forward annual dividend yield is 4.13%.
Moving Average
SANOFI’s worth is higher than its 50-day moving average of €90.27 and higher than its 200-day moving average of €90.25.
More news about SANOFI.
